Pfizer Inc.
PFE
$26.32
$0.060.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 4.50B | 12.86B | 21.47B | 29.05B | 31.37B |
| Total Depreciation and Amortization | 4.70B | 4.54B | 5.72B | 5.32B | 5.03B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.99B | -1.84B | -1.07B | -16.00M | -1.49B |
| Change in Net Operating Assets | -973.00M | -6.98B | -11.57B | -10.42B | -5.64B |
| Cash from Operations | 5.24B | 8.59B | 14.56B | 23.94B | 29.27B |
| Capital Expenditure | -3.10B | -3.05B | -3.90B | -3.73B | -3.24B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -43.43B | -16.80B | -16.80B | -16.77B | -23.00B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.36B | -6.73B | -6.52B | 7.47B | 10.45B |
| Cash from Investing | -33.17B | -26.58B | -27.21B | -13.04B | -15.78B |
| Total Debt Issued | 38.54B | 30.00B | 30.37B | 4.13B | 3.89B |
| Total Debt Repaid | -1.17B | -3.18B | -7.07B | -5.85B | -7.41B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | -2.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.93B | -6.86B | -9.11B | -9.04B | -8.98B |
| Other Financing Activities | -595.00M | -570.00M | -565.00M | -271.00M | -335.00M |
| Cash from Financing | 29.85B | 19.39B | 13.63B | -11.03B | -14.83B |
| Foreign Exchange rate Adjustments | -8.00M | -33.00M | -105.00M | -166.00M | -165.00M |
| Miscellaneous Cash Flow Adjustments | -3.00M | -2.00M | -2.00M | 0.00 | 0.00 |
| Net Change in Cash | 1.91B | 1.36B | 873.00M | -290.00M | -1.52B |
